CEO of Shalby Medtech subsidiary resigns effective Sept 4

Ceo ResignedManagement Changes View source PDF Explain this filing

SHALBY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹152.35

prior close

₹153.14

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-0.3% vs market

Hospital peers, median of 26sector+0.3%-0.3% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

+0.0

15m

+0.2

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+0.4-0.3+0.3-0.3

Next day

+1.7-0.2+1.9-0.8+2.5

+0.7+0.3+0.4-0.7+1.4

+0.1+0.6-0.5-0.4+0.5

+0.9+0.8+0.1-0.7+1.6

+1.7+0.4+1.4-0.2+1.9

+1.0+0.7+0.2-0.7+1.7

15d

-2.0+2.0-4.0-0.6-1.4

-9.4+0.7-10.2+1.2-10.6

-17.3-3.4-13.9-12.9-4.4

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Deepak Anand, CEO of Shalby Medtech Limited (a wholly-owned subsidiary of Shalby Limited), resigned to move abroad for personal reasons. His last working day is September 4, 2026. He is classified as Senior Management Personnel. No other material reasons cited and he has committed to a smooth handover.

Likely market impact

Limited direct impact on listed entity as change is at subsidiary level. Succession plan for Shalby Medtech to be watched.